View More Recent Stories

Feb 14, 2019 03:30PM MEI Pharma (MEIP), Helsinn Group Report Publication of Phase II Data for Pracinostat in Combination with Azacitidine in Blood Advances
Feb 14, 2019 03:22PM Helsinn and MEI Pharma Announce Publication of Phase II Data for Pracinostat in Combination with Azacitidine in Blood Advances
Dec 3, 2018 12:32PM MEI Pharma (MEIP), Heisinn Group Highlight Phase 2 Interim Data Evaluating the Combination of Pracinostat and Azacitidine in Patients with Myelodysplastic Syndrome
Dec 3, 2018 12:30PM Phase 2 Interim Data Evaluating the Combination of Pracinostat and Azacitidine in Patients with Myelodysplastic Syndrome Presented at the 2018 American Society of Hematology Annual Meeting
May 31, 2018 08:35AM MEI Pharma (MEIP) & Helsinn Group Report Successful Interim Analysis of Pracinostat/Azacitidine Phase 2 Combination Study in Higher Risk Myelodysplastic Syndrome Patients
May 31, 2018 08:30AM MEI Pharma and Helsinn Group Announce Successful Interim Analysis of Pracinostat/Azacitidine Phase 2 Combination Study in Higher Risk Myelodysplastic Syndrome (MDS) Patients
May 30, 2018 03:00AM Helsinn Group and MEI Pharma Announce Upcoming Presentation at ASCO 2018 on the design of the Phase III PRIMULA study of Pracinostat in combination with azacitidine for the treatment of Acute Myeloid
View More Recent Stories